<DOC>
	<DOCNO>NCT00047749</DOCNO>
	<brief_summary>The purpose study understand effect intrathecal ziconotide ( experimental pain medication ) dose slowly increase 3-week period patient severe chronic pain . During wean phase , study also gather information switch intrathecal IT medication ( slowly pump directly space around spine ) systemic pain medication ( mouth skin use patch ) . After weaned current IT medication , patient place IT ziconotide placebo ( non-active substance ) well allow stable dose systemic pain medication . Patients complete study may eligible long-term ziconotide therapy via extension protocol ELN92045-352 .</brief_summary>
	<brief_title>Prialt ( Ziconotide ) In Severe Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ziconotide</mesh_term>
	<mesh_term>omega-Conotoxins</mesh_term>
	<criteria>Patient able read , understand , voluntarily sign Institutional Review Board ( IRB ) approve , write informed consent document prior performance studyspecific procedure ; Patient must male female least 18 year age ; Patient must severe chronic pain IT therapy warrant ; Patient must willing able comply protocol , able maintain Patient Daily Diary Opioid Consumption ; Patient must implant programmable SynchroMedÂ® Infusion System place treatment chronic pain ; Female patient childbearing age agree use adequate , appropriate contraceptive method . Males partner ( ) childbearing age must use adequate , appropriate contraceptive method . Patient pregnant lactating ; Patient investigational drug ziconotide device within 30 day prior initiation study drug ; Patients know hypersensitivity ( allergy ) ziconotide excipients ( compound ) formulation ; Patient condition would contraindicate use IT analgesia , include presence infection microinfusion injection site ( needle insert abdomen fill pump medication ) , uncontrolled bleeding diathesis ( tendency bleed ) spinal canal obstruction impairs circulation Cerebral Spinal Fluid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>ziconotide</keyword>
	<keyword>Prialt</keyword>
	<keyword>intrathecal</keyword>
	<keyword>Synchromed</keyword>
</DOC>